Half Day Course: A Beginners Guide to Immunotherapy

In this half-day course, Dr Vickers describes the logic behind many immunotherapy-based cancer treatments, such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).